YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Natco Pharma
Natco Pharma
BSE: 524816NSE: NATCOPHARMISIN: INE987B01026

3rd-May-2021 08:08Source: BSE

Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

NATCO receives Emergency Use approval for Baricitinib
tablets for Covid-19 treatment

Sections